Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Small Cell Lung Carcinoma

arginyl-glycyl-aspartic acid has been researched along with Small Cell Lung Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, T; Hua, Z; Li, Y; Qiu, F; Qu, W; Shao, G; Tian, W; Wang, F; Zhang, Y1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Small Cell Lung Carcinoma

ArticleYear
(99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.
    Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:9

    Topics: Animals; Cell Line, Tumor; Humans; Integrin alphaVbeta3; Lung Neoplasms; Mice; Mice, Nude; Molecular Targeted Therapy; Multimodal Imaging; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays

2014